Advertisement
Screener

FINCH THERAPEUTICS GROUP, INC. Lease, Cost

FINCH THERAPEUTICS GROUP, INC. Lease, Cost

FINCH THERAPEUTICS GROUP, INC. reported Lease, Cost of $732.00 thousand for the 3-month period ending 2024-06-30, per its 10-Q filed 2024-08-13.

Discontinued › Expense Statement › Operating Expenses

us-gaap:LeaseCost · last filed 2024-08-13

  • FINCH THERAPEUTICS GROUP, INC. lease, cost for the quarter ending 2024-06-30 was $732.00K, a 9.63% decline year-over-year.
  • FINCH THERAPEUTICS GROUP, INC. lease, cost for the quarter ending 2024-03-31 was $581.00K, a 48.49% decline year-over-year.
  • FINCH THERAPEUTICS GROUP, INC. lease, cost for the quarter ending 2023-12-31 was -$586.00K, a 131.01% decline year-over-year.
  • FINCH THERAPEUTICS GROUP, INC. lease, cost for the quarter ending 2023-09-30 was $446.00K, a 77.78% decline year-over-year.
  • FINCH THERAPEUTICS GROUP, INC. lease, cost for fiscal 2023 was $1.89M, a 71.55% decline from fiscal 2022.
  • FINCH THERAPEUTICS GROUP, INC. lease, cost for fiscal 2022 was $6.65M, a 222.19% increase from fiscal 2021.
  • FINCH THERAPEUTICS GROUP, INC. lease, cost for fiscal 2021 was $2.06M.
Period endLease, Cost 3 monthLease, Cost 3 month as first filedLease, Cost 6 monthLease, Cost 6 month as first filedLease, Cost 9 monthLease, Cost 9 month as first filedLease, Cost 12 monthLease, Cost 12 month as first filed
2024-06-30$732.00K
10-Q · filed 2024-08-13
$1.31M
10-Q · filed 2024-08-13
$727.00K
derived: sum of 3 quarters · filed 2024-08-13
$1.17M
derived: sum of 4 quarters · filed 2024-08-13
2024-03-31$581.00K
10-Q · filed 2024-05-10
-$5.00K
derived: sum of 2 quarters · filed 2024-05-10
$441.00K
derived: sum of 3 quarters · filed 2024-05-10
$1.25M
derived: sum of 4 quarters · filed 2024-08-13
2023-12-31-$586.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-25
-$140.00K
derived: sum of 2 quarters · filed 2024-03-25
$670.00K
derived: sum of 3 quarters · filed 2024-08-13
$1.89M
10-K · filed 2024-03-25
2023-09-30$446.00K
10-Q · filed 2023-11-08
$1.26M
derived: sum of 2 quarters · filed 2024-08-13
$2.48M
10-Q · filed 2023-11-08
$4.27M
derived: sum of 4 quarters · filed 2024-08-13
2023-06-30$810.00K
10-Q · filed 2024-08-13
$2.04M
10-Q · filed 2024-08-13
$3.83M
derived: sum of 3 quarters · filed 2024-08-13
$5.83M
derived: sum of 4 quarters · filed 2024-08-13
2023-03-31$1.13M
10-Q · filed 2024-05-10
$1.13M
10-Q · filed 2023-05-10
$3.02M
derived: sum of 2 quarters · filed 2024-05-10
$5.03M
derived: sum of 3 quarters · filed 2024-05-10
$6.84M
derived: sum of 4 quarters · filed 2024-05-10
2022-12-31$1.89M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-25
$3.90M
derived: sum of 2 quarters · filed 2024-03-25
$5.71M
derived: sum of 3 quarters · filed 2024-03-25
$6.65M
10-K · filed 2024-03-25
$6.68M
10-K · filed 2023-03-23
2022-09-30$2.01M
10-Q · filed 2023-11-08
$2.01M
10-Q · filed 2022-11-10
$3.82M
derived: sum of 2 quarters · filed 2023-11-08
$4.76M
10-Q · filed 2023-11-08
$4.78M
10-Q · filed 2022-11-10
$5.46M
derived: sum of 4 quarters · filed 2023-11-08
2022-06-30$1.81M
10-Q/A · filed 2023-08-11
$1.81M
10-Q · filed 2022-08-11
$2.75M
10-Q/A · filed 2023-08-11
$2.77M
10-Q · filed 2022-08-11
$3.46M
derived: sum of 3 quarters · filed 2023-08-11
$4.03M
derived: sum of 4 quarters · filed 2023-08-11
2022-03-31$953.00K
10-Q · filed 2023-05-10
$1.65M
derived: sum of 2 quarters · filed 2023-05-10
$2.22M
derived: sum of 3 quarters · filed 2023-05-10
$2.67M
derived: sum of 4 quarters · filed 2023-05-10
2021-12-31$693.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23
$1.27M
derived: sum of 2 quarters · filed 2023-03-23
$1.72M
derived: sum of 3 quarters · filed 2023-03-23
$2.06M
10-K · filed 2023-03-23
2021-09-30$574.00K
10-Q · filed 2022-11-10
$1.03M
derived: sum of 2 quarters · filed 2022-11-10
$1.37M
10-Q · filed 2022-11-10
2021-06-30$453.00K
10-Q · filed 2022-08-11
$797.00K
10-Q · filed 2022-08-11
2021-03-31$344.00K
10-Q · filed 2022-05-16